1. Home
  2. NNDM vs PBYI Comparison

NNDM vs PBYI Comparison

Compare NNDM & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.52

Market Cap

401.4M

Sector

Technology

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$8.56

Market Cap

428.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNDM
PBYI
Founded
2012
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
401.4M
428.1M
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
NNDM
PBYI
Price
$1.52
$8.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.7M
376.3K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$102,437,000.00
$27,685,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
77.30
N/A
52 Week Low
$1.19
$3.03
52 Week High
$2.32
$8.66

Technical Indicators

Market Signals
Indicator
NNDM
PBYI
Relative Strength Index (RSI) 55.76 66.22
Support Level $1.48 $6.50
Resistance Level $1.85 N/A
Average True Range (ATR) 0.06 0.38
MACD 0.02 0.02
Stochastic Oscillator 100.00 88.88

Price Performance

Historical Comparison
NNDM
PBYI

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provides industrial manufacturing solutions for the design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, and industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research, and academia, along with government organizations.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: